Neoadjuvant Chemotherapy Combined with Immunotherapy

DRUG2 trials

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Obstetrics & Gynecology Hospital of Fudan University

Conditions

Cervical CancersHER2-Negative Locally Advanced Breast Cancer

Phase 2

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

RecruitingNCT06908668

Cancer Institute and Hospital, Chinese Academy of Medical SciencesHER2-Negative Locally Advanced Breast Cancer

Start: 2025-03-31End: 2028-09-10Target: 170Updated: 2026-06-10

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

RecruitingNCT07130240

Obstetrics & Gynecology Hospital of Fudan UniversityCervical Cancers

Start: 2025-08-15End: 2030-08-31Target: 20Updated: 2025-08-19